Vickerman Investment Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.93M Sell
38,353
-2,209
-5% -$259K 0.96% 27
2026
Q1
$4.88M Sell
40,562
-856
-2% -$98.8K 1.03% 24
2025
Q4
$4.36M Sell
41,418
-8,570
-17% -$804K 0.87% 28
2025
Q3
$4.2M Buy
49,988
+5,455
+12% +$449K 0.85% 33
2025
Q2
$3.53M Buy
44,533
+7,329
+20% +$583K 0.76% 39
2025
Q1
$3.34M Buy
37,204
+8,921
+32% +$833K 0.76% 34
2024
Q4
$2.81M Buy
28,283
+151
+0.5% +$15.6K 0.76% 40
2024
Q3
$3.19M Buy
28,132
+133
+0.5% +$15.8K 0.94% 39
2024
Q2
$3.47M Sell
27,999
-314
-1% -$40.4K 1.11% 29
2024
Q1
$3.74M Sell
28,313
-548
-2% -$67.5K 1.21% 24
2023
Q4
$3.15M Sell
28,861
-775
-3% -$80.4K 1.07% 31
2023
Q3
$3.05M Sell
29,636
-419
-1% -$45.2K 1.25% 28
2023
Q2
$3.47M Sell
30,055
-503
-2% -$57.1K 1.35% 24
2023
Q1
$3.25M Sell
30,558
-1,087
-3% -$117K 1.28% 24
2022
Q4
$3.51M Buy
31,645
+3,590
+13% +$367K 1.59% 17
2022
Q3
$2.42M Buy
28,055
+3,870
+16% +$345K 1.17% 34
2022
Q2
$2.21M Buy
24,185
+8,599
+55% +$762K 1.04% 39
2022
Q1
$1.38M Buy
+15,586
New +$1.23M 0.61% 46

Other funds holding MRK

Vickerman Investment Advisors's MRK Position: Q2 2026 in Review

Vickerman Investment Advisors reduced its Merck (MRK) stake by 5.4% in Q2 2026, selling an estimated $259K and leaving 38,353 shares worth $4.93M. The position accounts for 0.96% of the portfolio, ranked #27.

Vickerman Investment Advisors first reported a position in MRK in Q1 2022 and has held it in 18 quarters since. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Vickerman Investment Advisors held 38,353 shares of Merck worth $4.93M as of Q2 2026.
  • Vickerman Investment Advisors sold 2,209 Merck shares in Q2 2026, an estimated $259K.
  • Merck made up 0.96% of Vickerman Investment Advisors's portfolio in Q2 2026, its #27 holding.
  • Vickerman Investment Advisors first reported a position in Merck in Q1 2022 and has held it in 18 quarters since.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Vickerman Investment Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.